Citation

Edmund Capparelli, Pharm.D., John L. Sullivan, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Elaine Margaret Smith, M.D., Bobbie L. Graham, B.S., Bobbie L. Graham, B.S., Paula Britto, M.S., Mark I. Becker, Pharm.D., Diane Holland, M.Phil., James D. Connor, M.D., Katherine Luzuriaga, M.D. Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants. Pediatric Infectious Disease Journal. 2001 Sep 24; 20(8):746-51.

Citation

Elizabeth (Betsy) J. McFarland, M.D., William Borkowsky, M.D., Terence Fenton, Ed.D., Diane W. Wara, M.D., James McNamara, M.D., Pearl Samson, M.S., Minhee Kang, M.S., Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Coleen K. Cunningham, M.D., Anne-Marie Duliege, M.D., M.S., Faruk Sinangil, Stephen A. Spector, M.D., Eleanor Jimenez, M.D., F.A.A.P., Yvonne J. Bryson, M.D., Sandra K. Burchett, M.D., M.S., Lisa M. Frenkel, M.D., Ram Yogev, M.D., Francis Gigliotti, M.D., Katherine Luzuriaga, M.D., Robert Livingston, M.D. Human Immunodeficiency Virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. Journal of Infectious Diseases. 2001 Nov 30; 184(10):1331-1335.

Citation

Laura Smeaton, M.S., Victor DeGruttola, Sc.D., Gregory K. Robbins, M.D., M.P.H., Robert Shafer, M.D. ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1. Controlled Clinical Trials. 2001 Apr 01; 22(2):142-59.

Citation

Hernan Valdez, M.D., Julia A. Metcalf, Barbara Gripshover, M.D., Jeffrey M. Jacobson, M.D., Ronald T. Mitsuyasu, M.D., Michael M. Lederman, M.D. Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients. AIDS. 2001 Mar 01; 15(5):661-2.

Citation

Helene Hardy, Pharm.D., Lori Esch, Pharm.D., Gene D. Morse, Pharm.D. Glucose disorders associated with HIV and its drug therapy. Annals of Pharmacotherapy. 2001 Mar 01; 35(3):343-51.

Citation

Catherine Leport, M.D., J. Franck, Genevieve Chene, F. Derouin, JL Ecobichon, Sophie Pueyo, Jose Miro, Benjamin J. Luft, M.D., Philippe Morlat, M.D., H. Dumon. Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus. Clinical and Diagnostic Laboratory Immunology. 2001 May 01; 8(3):579-84.

Citation

David M. Simpson, M.D., David Katzenstein, M.D., Bettina Haidich, M.Sc., David Millington, Constantin Yiannoutsos, Ph.D., Giovanni Schifitto, M.D., Justin C. McArthur, M.B.B.S., M.P.H. Plasma carnitine in HIV-associated neuropathy. AIDS. 2001 Nov 09; 15(16):2207-8.

Citation

Mark Mirochnick, M.D., Ellen Rae Cooper, M.P.H., M.D., Edmund Capparelli, Pharm.D., Kenneth McIntosh, M.D., Jane C. Lindsey, Sc.D., Ph.D., Jing Xu, M.S., David P. Jacobus, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Vincent R. Bonagura, M.D., Sharon Appelbaum Nachman, M.D., Ram Yogev, M.D., Stephen A. Spector, M.D. Population pharmacokinetics of dapson in children with human immunodeficiency virus infection. Clinical Pharmacology & Therapeutics. 2001 Jul 07; 1(70):24-32.

Citation

Elizabeth Livingston, M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Jorge Gandia, M.D., Mary Jo O'Sullivan, M.D., Sharon Huang, M.S., Ross E. McKinney, Jr., M.D., W. N.P. Herbert, Pamela A. Clax, D.P.M., Yi Wang, Ph.D., Sheran Patel, D.O., Ruth E. Dickover, Ph.D., Jashvant D. Unadkat, Ph.D. Maternal and Fetal Clinical Effects Of Didanosine (ddl) Use In Pregnancies Complicated By HIV-1 Infection. American Journal of Obstetrics and Gynecology. 2001 Aug 01;